SNTI SENTI BIOSCIENCES HOLDINGS I revenue, earnings and financials

For the quarter ended June 30, 2026, SENTI BIOSCIENCES HOLDINGS I reported revenue of $17.0K, net income of −$12.8M and diluted EPS of −$0.41; for the fiscal year ended December 2025 revenue was $22.0K.

SNTI annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $22.0K, gross profit n/a, operating income −$68.8M, net income −$61.4M (margin -279263.6%), EPS −$2.73
• Fiscal year ended Dec 2024: revenue $0, gross profit n/a, operating income −$61.0M, net income −$52.8M (margin n/a), EPS −$12.03
• Fiscal year ended Dec 2023: revenue $2.56M, gross profit n/a, operating income −$92.7M, net income −$71.1M (margin -2774.6%), EPS −$16.01
• Fiscal year ended Dec 2022: revenue $4.29M, gross profit n/a, operating income −$62.1M, net income −$58.2M (margin -1358.1%), EPS −$2.23
• Fiscal year ended Dec 2021: revenue $2.76M, gross profit n/a, operating income −$40.4M, net income −$55.3M (margin -2003.6%), EPS −$19.00

SNTI quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $17.0K, net income −$12.8M, EPS −$0.41
• Quarter ended Mar 31, 2026: revenue $16.0K, net income −$4.22M, EPS −$0.14
• Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$14.5M, EPS −$0.07
• Quarter ended Sep 30, 2025: revenue n/a, net income −$18.1M, EPS −$0.69
• Quarter ended Jun 30, 2025: revenue $0, net income −$14.7M, EPS −$0.56
• Quarter ended Mar 31, 2025: revenue $0, net income −$14.1M, EPS −$1.41
• Quarter ended Dec 31, 2024 (from the annual report): revenue $0, net income −$610K, EPS −$0.62
• Quarter ended Sep 30, 2024: revenue $0 (down 100.0% year over year), net income −$28.9M, EPS −$6.31
• Quarter ended Jun 30, 2024: revenue $0 (down 100.0% year over year), net income −$11.2M, EPS −$2.45
• Quarter ended Mar 31, 2024: revenue $0 (down 100.0% year over year), net income −$12.1M, EPS −$2.65
• Quarter ended Dec 31, 2023 (from the annual report): revenue $0 (down 100.0% year over year), net income −$71.1M, EPS −$8.01
• Quarter ended Sep 30, 2023: revenue $338K (down 80.9% year over year), net income −$14.9M, EPS −$3.36
• Quarter ended Jun 30, 2023: revenue $937K (down 31.0% year over year), net income −$18.7M, EPS −$4.22
• Quarter ended Mar 31, 2023: revenue $1.29M (up 16.5% year over year), net income −$18.7M, EPS −$0.42
• Quarter ended Dec 31, 2022 (from the annual report): revenue $58.0K, net income −$58.2M, EPS $2.73
• Quarter ended Sep 30, 2022: revenue $1.77M (up 60.1% year over year), net income −$16.6M, EPS −$0.38
• Quarter ended Jun 30, 2022: revenue $1.36M (up 71.2% year over year), net income −$11.6M, EPS −$0.86
• Quarter ended Mar 31, 2022: revenue $1.10M, net income −$11.8M, EPS −$3.72
• Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$10.9M, EPS n/a
• Quarter ended Sep 30, 2021: revenue $1.10M, net income −$11.4M, EPS −$3.90

SNTI cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$43.4M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$41.4M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$52.4M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$34.9M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$34.6M, share buybacks n/a

SNTI balance sheet

• Jun 30, 2026: cash $6.46M, total assets $33.1M, total liabilities $36.5M, shareholders' equity −$3.40M
• Mar 31, 2026: cash $8.94M, total assets $38.2M, total liabilities $35.7M, shareholders' equity $2.57M
• Dec 31, 2025: cash $16.4M, total assets $51.2M, total liabilities $45.6M, shareholders' equity $5.59M
• Sep 30, 2025: cash $12.2M, total assets $52.7M, total liabilities $44.6M, shareholders' equity $8.12M
• Jun 30, 2025: cash $21.6M, total assets $68.5M, total liabilities $43.9M, shareholders' equity $24.7M
• Mar 31, 2025: cash $33.8M, total assets $82.8M, total liabilities $44.9M, shareholders' equity $37.9M
• Dec 31, 2024: cash $48.3M, total assets $97.8M, total liabilities $47.1M, shareholders' equity $25.6M
• Sep 30, 2024: cash $10.5M, total assets $57.7M, total liabilities $41.7M, shareholders' equity $16.0M

What is SNTI's revenue?

SENTI BIOSCIENCES HOLDINGS I reported $22.0K of revenue for the fiscal year ended December 2025.

Is SNTI profitable?

No. SENTI BIOSCIENCES HOLDINGS I lost $49.6M over the last four quarters.

What is SNTI's EPS?

Diluted earnings per share over the last four quarters were −$1.31; −$0.41 in the latest quarter.

SNTI ownership and insider trades · All stocks